GTx, Inc. (GTXI) Announces Enobosarm Phase 2 Achieved Stage 1 Milestone
Tweet Send to a Friend
GTx, Inc. (Nasdaq: GTXI) announced the achievement of the Stage 1 milestone for the 18 mg cohort of its Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
